# Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia

> **NCT01761227** · PHASE2 · COMPLETED · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 240 (actual)

## Conditions studied

- Vascular Dementia

## Interventions

- **DRUG:** Fufangdanshen Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01761227
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2018-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761227, "Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01761227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*